CODA ZERO is here. St Emlyn’s
This week marks the return of CODA, or rather the start of the CODA project that developed from the genre changing SMACC conferences. I was lucky enough to be involved […]
CODA ZERO is here. St Emlyn’s Read More
Covid-19 in Italy with Roberto Cosentini part 2. St Emlyn’s
Ed – Back at the beginning of the pandemic we had a fantastic contribution from our friend and colleague Roberto Cosentini on the Bergamo experience of dealing with this terrible
Covid-19 in Italy with Roberto Cosentini part 2. St Emlyn’s Read More
Top trauma papers of 2019-2020. St Emlyn’s
The top ten trauma papers of 2019-20
Top trauma papers of 2019-2020. St Emlyn’s Read More
Dexamethasone, COVID-19 and the RECOVERY trial. St Emlyn’s
We have previously covered the RECOVERY trial on St Emlyn’s noting that the first results out of this large pragmatic, adaptive design platform RCT showed no benefit to Hydroxychloroquine. A
Dexamethasone, COVID-19 and the RECOVERY trial. St Emlyn’s Read More
COVID Journal Club #8 – The Webinar. Thursday 18th 11am BST
We took a well earned break last week from the weekly Covid19 webinar and journal club, but we are back on Thursday with 51–5+1 papers to keep us all thinking
COVID Journal Club #8 – The Webinar. Thursday 18th 11am BST Read More
Podcast – May 2020 Monthly Round Up
It’s been another month of Covid complexity and more. I got together with Iain Beardsell to talk through the highlights of the month on the blog and podcast. Much has
Podcast – May 2020 Monthly Round Up Read More
The RECOVERY platform trial: No benefit to Hydroxychloroquine in Covid-19. St Emlyn’s
We’ve talked about the RECOVERY trial on the blog and podcast before. This is a UK based platform trial (more on this later) looking at patients admitted to hospital with
The RECOVERY platform trial: No benefit to Hydroxychloroquine in Covid-19. St Emlyn’s Read More
Covid19: Why we need Evidence Based Medicine (EBM) more than ever during a pandemic. St Emlyn’s
Evidence based medicine (EBM) is one of the four pillars of St Emlyn’s. We are usually pretty sceptical about adopting treatments without high quality evidence publishfred in a decent journal